<!DOCTYPE html>
<!-- Generated by pkgdown: do not edit by hand --><html lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta charset="utf-8"><meta http-equiv="X-UA-Compatible" content="IE=edge"><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><title>Break a phase I outcome string into a list of cohort parts. — phase1_outcomes_to_cohorts • escalation</title><!-- favicons --><link rel="icon" type="image/png" sizes="96x96" href="../favicon-96x96.png"><link rel="icon" type="”image/svg+xml”" href="../favicon.svg"><link rel="apple-touch-icon" sizes="180x180" href="../apple-touch-icon.png"><link rel="icon" sizes="any" href="../favicon.ico"><link rel="manifest" href="../site.webmanifest"><script src="../deps/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><link href="../deps/bootstrap-5.3.1/bootstrap.min.css" rel="stylesheet"><script src="../deps/bootstrap-5.3.1/bootstrap.bundle.min.js"></script><link href="../deps/font-awesome-6.5.2/css/all.min.css" rel="stylesheet"><link href="../deps/font-awesome-6.5.2/css/v4-shims.min.css" rel="stylesheet"><script src="../deps/headroom-0.11.0/headroom.min.js"></script><script src="../deps/headroom-0.11.0/jQuery.headroom.min.js"></script><script src="../deps/bootstrap-toc-1.0.1/bootstrap-toc.min.js"></script><script src="../deps/clipboard.js-2.0.11/clipboard.min.js"></script><script src="../deps/search-1.0.0/autocomplete.jquery.min.js"></script><script src="../deps/search-1.0.0/fuse.min.js"></script><script src="../deps/search-1.0.0/mark.min.js"></script><!-- pkgdown --><script src="../pkgdown.js"></script><meta property="og:title" content="Break a phase I outcome string into a list of cohort parts. — phase1_outcomes_to_cohorts"><meta name="description" content="Break a phase I outcome string into a list of cohort parts.
Break a phase I outcome string into a list of cohort parts.
The outcome string describes the doses given, outcomes observed and the
timing of analyses that recommend a dose. The format of the string is
described in Brock (2019), and that itself is the phase I analogue of the
similar idea described in Brock _et al_. (2017).
The letters T and N are used to represents patients that experienced
(T)oxicity and (N)o toxicity. These letters are concatenated after numerical
dose-levels to convey the outcomes of cohorts of patients.
For instance, 2NNT represents a cohort of three patients that were
treated at dose-level 2, one of whom experienced toxicity, and two that did
not. The results of cohorts are separated by spaces and it is assumed that a
dose-finding decision takes place at the end of a cohort. Thus,
2NNT 1NN builds on our previous example, where the next cohort of two
were treated at dose-level 1 and neither of these patients experienced
toxicity. See examples."><meta property="og:description" content="Break a phase I outcome string into a list of cohort parts.
Break a phase I outcome string into a list of cohort parts.
The outcome string describes the doses given, outcomes observed and the
timing of analyses that recommend a dose. The format of the string is
described in Brock (2019), and that itself is the phase I analogue of the
similar idea described in Brock _et al_. (2017).
The letters T and N are used to represents patients that experienced
(T)oxicity and (N)o toxicity. These letters are concatenated after numerical
dose-levels to convey the outcomes of cohorts of patients.
For instance, 2NNT represents a cohort of three patients that were
treated at dose-level 2, one of whom experienced toxicity, and two that did
not. The results of cohorts are separated by spaces and it is assumed that a
dose-finding decision takes place at the end of a cohort. Thus,
2NNT 1NN builds on our previous example, where the next cohort of two
were treated at dose-level 1 and neither of these patients experienced
toxicity. See examples."><meta property="og:image" content="/logo.png"></head><body>
    <a href="#main" class="visually-hidden-focusable">Skip to contents</a>


    <nav class="navbar navbar-expand-lg fixed-top bg-light" data-bs-theme="light" aria-label="Site navigation"><div class="container">

    <a class="navbar-brand me-2" href="../index.html">escalation</a>

    <small class="nav-text text-muted me-auto" data-bs-toggle="tooltip" data-bs-placement="bottom" title="">0.2.3</small>


    <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbar" aria-controls="navbar" aria-expanded="false" aria-label="Toggle navigation">
      <span class="navbar-toggler-icon"></span>
    </button>

    <div id="navbar" class="collapse navbar-collapse ms-3">
      <ul class="navbar-nav me-auto"><li class="active nav-item"><a class="nav-link" href="../reference/index.html">Reference</a></li>
<li class="nav-item dropdown">
  <button class="nav-link dropdown-toggle" type="button" id="dropdown-articles" data-bs-toggle="dropdown" aria-expanded="false" aria-haspopup="true">Articles</button>
  <ul class="dropdown-menu" aria-labelledby="dropdown-articles"><li><a class="dropdown-item" href="../articles/A100-DoseSelectors.html">Using escalation</a></li>
    <li><a class="dropdown-item" href="../articles/A205-CRM.html">CRM - Continual Reassessment Method</a></li>
    <li><a class="dropdown-item" href="../articles/A207-NBG.html">NBG - Neuenschwander, Branson &amp; Gsponer</a></li>
    <li><a class="dropdown-item" href="../articles/A210-TPI.html">TPI - Toxicity Probability Interval Design</a></li>
    <li><a class="dropdown-item" href="../articles/A220-mTPI.html">mTPI - Modified Toxicity Probability Interval Design</a></li>
    <li><a class="dropdown-item" href="../articles/A230-BOIN.html">BOIN - Bayesian Optimal Interval Design</a></li>
    <li><a class="dropdown-item" href="../articles/A280-TITE.html">TITE-CRM and TITE-NBG - Time-to-Event Designs</a></li>
    <li><a class="dropdown-item" href="../articles/A310-EfficacyToxicity.html">EffTox, Wages &amp; Tait, and BOIN12 - Efficacy &amp; Toxicity Designs</a></li>
    <li><a class="dropdown-item" href="../articles/A360-Combinations.html">BOIN-COMB - Treatment Combination Designs</a></li>
    <li><a class="dropdown-item" href="../articles/A600-DosePaths.html">Working with dose-paths</a></li>
    <li><a class="dropdown-item" href="../articles/A700-Simulation.html">Simulating dose-escalation trials</a></li>
    <li><a class="dropdown-item" href="../articles/A710-SimulationComparison.html">Comparing dose-escalation designs by simulation</a></li>
  </ul></li>
<li class="nav-item"><a class="nav-link" href="../news/index.html">Changelog</a></li>
      </ul><ul class="navbar-nav"><li class="nav-item"><form class="form-inline" role="search">
 <input class="form-control" type="search" name="search-input" id="search-input" autocomplete="off" aria-label="Search site" placeholder="Search for" data-search-index="../search.json"></form></li>
<li class="nav-item"><a class="external-link nav-link" href="https://github.com/brockk/escalation/" aria-label="GitHub"><span class="fa fab fa-github fa-lg"></span></a></li>
      </ul></div>


  </div>
</nav><div class="container template-reference-topic">
<div class="row">
  <main id="main" class="col-md-9"><div class="page-header">
      <img src="../logo.png" class="logo" alt=""><h1>Break a phase I outcome string into a list of cohort parts.</h1>
      <small class="dont-index">Source: <a href="https://github.com/brockk/escalation/blob/master/R/phase1_outcomes_to_cohorts.R" class="external-link"><code>R/phase1_outcomes_to_cohorts.R</code></a></small>
      <div class="d-none name"><code>phase1_outcomes_to_cohorts.Rd</code></div>
    </div>

    <div class="ref-description section level2">
    <p>Break a phase I outcome string into a list of cohort parts.</p>
<p>Break a phase I outcome string into a list of cohort parts.</p>
<p>The outcome string describes the doses given, outcomes observed and the
timing of analyses that recommend a dose. The format of the string is
described in Brock (2019), and that itself is the phase I analogue of the
similar idea described in Brock _et al_. (2017).</p>
<p>The letters T and N are used to represents patients that experienced
(T)oxicity and (N)o toxicity. These letters are concatenated after numerical
dose-levels to convey the outcomes of cohorts of patients.
For instance, <code>2NNT</code> represents a cohort of three patients that were
treated at dose-level 2, one of whom experienced toxicity, and two that did
not. The results of cohorts are separated by spaces and it is assumed that a
dose-finding decision takes place at the end of a cohort. Thus,
<code>2NNT 1NN</code> builds on our previous example, where the next cohort of two
were treated at dose-level 1 and neither of these patients experienced
toxicity. See examples.</p>
    </div>

    <div class="section level2">
    <h2 id="ref-usage">Usage<a class="anchor" aria-label="anchor" href="#ref-usage"></a></h2>
    <div class="sourceCode"><pre class="sourceCode r"><code><span><span class="fu">phase1_outcomes_to_cohorts</span><span class="op">(</span><span class="va">outcomes</span><span class="op">)</span></span></code></pre></div>
    </div>

    <div class="section level2">
    <h2 id="arguments">Arguments<a class="anchor" aria-label="anchor" href="#arguments"></a></h2>


<dl><dt id="arg-outcomes">outcomes<a class="anchor" aria-label="anchor" href="#arg-outcomes"></a></dt>
<dd><p>character string representing the doses given, outcomes
observed, and timing of analyses. See Description.</p></dd>

</dl></div>
    <div class="section level2">
    <h2 id="value">Value<a class="anchor" aria-label="anchor" href="#value"></a></h2>
    <p>a list with a slot for each cohort. Each cohort slot is itself a
list, containing elements:
* <code>dose</code>, the integer dose delivered to the cohort;
* <code>outcomes</code>, a character string representing the <code>T</code> or <code>N</code>
 outcomes for the patients in this cohort.</p>
    </div>
    <div class="section level2">
    <h2 id="references">References<a class="anchor" aria-label="anchor" href="#references"></a></h2>
    <p>Brock, K. (2019). trialr: Bayesian Clinical Trial Designs in R and Stan.
arXiv:1907.00161 [stat.CO]</p>
<p>Brock, K., Billingham, L., Copland, M., Siddique, S., Sirovica, M., &amp; Yap, C.
(2017). Implementing the EffTox dose-finding design in the Matchpoint trial.
BMC Medical Research Methodology, 17(1), 112.
https://doi.org/10.1186/s12874-017-0381-x</p>
    </div>

    <div class="section level2">
    <h2 id="ref-examples">Examples<a class="anchor" aria-label="anchor" href="#ref-examples"></a></h2>
    <div class="sourceCode"><pre class="sourceCode r"><code><span class="r-in"><span><span class="va">x</span> <span class="op">=</span> <span class="fu">phase1_outcomes_to_cohorts</span><span class="op">(</span><span class="st">'1NNN 2NNT 3TT'</span><span class="op">)</span></span></span>
<span class="r-in"><span><span class="fu"><a href="https://rdrr.io/r/base/length.html" class="external-link">length</a></span><span class="op">(</span><span class="va">x</span><span class="op">)</span></span></span>
<span class="r-out co"><span class="r-pr">#&gt;</span> [1] 3</span>
<span class="r-in"><span><span class="va">x</span><span class="op">[[</span><span class="fl">1</span><span class="op">]</span><span class="op">]</span><span class="op">$</span><span class="va">dose</span></span></span>
<span class="r-out co"><span class="r-pr">#&gt;</span> [1] 1</span>
<span class="r-in"><span><span class="va">x</span><span class="op">[[</span><span class="fl">1</span><span class="op">]</span><span class="op">]</span><span class="op">$</span><span class="va">outcomes</span></span></span>
<span class="r-out co"><span class="r-pr">#&gt;</span> [1] "NNN"</span>
<span class="r-in"><span><span class="va">x</span><span class="op">[[</span><span class="fl">2</span><span class="op">]</span><span class="op">]</span><span class="op">$</span><span class="va">dose</span></span></span>
<span class="r-out co"><span class="r-pr">#&gt;</span> [1] 2</span>
<span class="r-in"><span><span class="va">x</span><span class="op">[[</span><span class="fl">2</span><span class="op">]</span><span class="op">]</span><span class="op">$</span><span class="va">outcomes</span></span></span>
<span class="r-out co"><span class="r-pr">#&gt;</span> [1] "NNT"</span>
<span class="r-in"><span><span class="va">x</span><span class="op">[[</span><span class="fl">3</span><span class="op">]</span><span class="op">]</span><span class="op">$</span><span class="va">dose</span></span></span>
<span class="r-out co"><span class="r-pr">#&gt;</span> [1] 3</span>
<span class="r-in"><span><span class="va">x</span><span class="op">[[</span><span class="fl">3</span><span class="op">]</span><span class="op">]</span><span class="op">$</span><span class="va">outcomes</span></span></span>
<span class="r-out co"><span class="r-pr">#&gt;</span> [1] "TT"</span>
<span class="r-in"><span></span></span>
</code></pre></div>
    </div>
  </main><aside class="col-md-3"><nav id="toc" aria-label="Table of contents"><h2>On this page</h2>
    </nav></aside></div>


    <footer><div class="pkgdown-footer-left">
  <p>Developed by Kristian Brock, Daniel Slade, Michael Sweeting.</p>
</div>

<div class="pkgdown-footer-right">
  <p>Site built with <a href="https://pkgdown.r-lib.org/" class="external-link">pkgdown</a> 2.1.3.</p>
</div>

    </footer></div>





  </body></html>

